Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
01 1Aptra Synthesis
02 1Wuxi Further Pharmaceutical Co Ltd
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
CAS Number : 873-83-6
End Use API :
End Use API : Burixafor, Etravirine, Sulfadimethoxine
About the Company : Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP st...
CAS Number : 873-83-6
End Use API :
End Use API :
About the Company : Further Pharmaceutical (www.further-pharm.com) is an innovation-driven and service-oriented biopharmaceutical company with global operations that develops and manufactures specialty and...
LOOKING FOR A SUPPLIER?